(2) Nowicky J.W. Cancer Treatment Using Anticancer Preparation Alkaloid Derivative Ukrain. IV Mediterranean Congress of Chemotherapy, 19-25 October 1984, Rhodos, Greece, Chemioterapia, Supplement to n. 2, Volume 4, 1169, April 1985.

(4) Nowicky J.W., Greif M., Hamler F., Hiesmayr W. and Staub W. Macroscopic UV-Marking through Affinity. Journal of Tumor Marker Oncology, Volume 3, Number 4, 463, 1988.

(12) Liepins Andrejs and Nowicky Jaroslaw W. Ukrain is Selectively Cytostatic and/or Cytotoxic to Human Tumor and HIV-Infected Cell but not to Human Normal Cells. Recent Advances in Chemotherapy, Anticancer Section, Proceedings of the 17th International Congress of Chemotherapy, Berlin, 2660, 1991.

(17) Liepins Andrejs and Nowicky Jaroslaw W. Activation of Spleen Cell Lytic Activity by the Alkaloid Thiophophoric Acid Derivative: Ukrain. International Journal of Immunopharmacology, 14, 8, 1437, 1992.

(21) Musianowycz J., Judmajer F., Manfreda D., Spängler P., Albrecht H., Hoffmann J., Meijer D. Clinical Studies of Ukrain in Terminal Cancer Patients (Phase II). Drugs Exptl. Clin. Res., XVIII, 45, 1992.

(22) Danilos J., Zbroja-Sontag W., Baran E., Kutylcio L., Kondratowicz L., Jusiak L. Preliminary studies on the effect of Ukrain (Tris {2-{[5BS-(5BA,6B, 12BA)]-5B,6,7,12B,13,14-hexahydro-13-methyl[1,3] benzodioxolo [5,6-C]-1-3-dioxolo[4,5,-I] phenanthri-dinium-6-ol}-ethaneaminyl} phosphineslfide.6HCl) on the immunological response in patients with malignant tumours. Drugs Exptl. Clin. Res., XVIII, 55, 1992.

(24) Nowicky J.W., Manolakis G., Meijer D., Vatanasapt V., Brzosko W.J. Ukrain both as an anticancer and immunoregulatory agent. Drugs Exptl. Clin. Res., XVIII, 51, 1992.

(26) Sotomayor E., Rao K., Lopez D.M., Liepins A. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies. Drugs Exptl. Clin. Res., XVIII, 5, 1992.

(28) Lohninger A., Hamler F. Chelidonium majus L. (Ukrain) in the treatment of cancer patients. Drugs Exptl. Clin. Res., XVIII, 73, 1992.

(41) Nowicky J.W. Ukrain Antineoplastic Immunostimulant. E09/029, NSC-631570, NSC-B238865, UKSR-222, W122, Drugs of the Future, Prous Science Publishers, Copyright Prous Science, 18, 11, 1015, November 1993.

(43) Liepins A., Sotomayor E. M., Lopez D. M. and J.W. Nowicky. Biological Response-Modifying Properties of the Alkaloid Derivative Ukrain (NSC 631570). Recent Advances in Chemotherapy, American Society for Microbiology, Proceedings of the 18th International Congress of Chemotherapy, Stockholm, Sweden, June 27-July 2, 783, 1993.

(44) Nowicky J. W., Manolakis G., Meijer D., Vatanasapt V., Brzosko W.J. and Lohninger A. Immunological and Tumoricidal Properties of Ukrain. Recent Advances in Chemotherapy, American Society for Microbiology, Proceedings of the 18th International Congress of Chemotherapy, Stockholm, Sweden, June 27-July 2, 793, 1993.

(45) Lohninger A., Musianowycz J., Judmaier F., Manfreda D., Spängler P., Albrecht H., Hoffmann J. and Mejer D. Results of Phase II Clinical Studies with Ukrain. Recent Advances in Chemotherapy, American Society for Microbiology, Proceedings of the 18th International Congress of Chemotherapy, Stockholm, Sweden, June 27-July 2, 794, 1993.

(54) Brzosko W.J., Uglianica K., Fomin K., Nowicky J.W. Influence of ukrain on breast carcinomas. 11th Future Trends in Chemotherapy, Interdisciplinary World Congress on Antimicrobial and Anticancer Drugs, 24-27 April 1994, Palexpo Geneva (Switzerland), Abstracts: abs. 109, April 1994.

(64) Nowicky J.W., Hiesmayr W. Influence of Ukrain on Human Xenografts in vitro. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 21 - 25.

(65) Jin Y.M., Nowicky J.W., Liepins A. Mitogenic Properties of Ukrain (NSC-631570) on Human Peripherial Blood Monocytes: Clinical Implications. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 27 - 30.

(66) Liepins A., Nowicky J.W. Modulation of Immune Effector Cell Cytolytic Activity and Tumour Growth Inhibition in vivo by Ukrain (NSC-631570). Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 31 - 42.

(68) Uglanica K.N., Fomin K.A., Nefyodov L.I., Nowicky J.W., Brzosko W.J., Jankowski A. Influence of Ukrain on Patients with Surgically Treated Breast Cancer (Introductory Remarks). Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 51 - 54.

(69) Uglanica K.N., Brzosko W.J, Fomin K.A., Nowicky J.W. Influence of Ukrain on Breast Cancer. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 55 - 62.

(70) Uglanica K.N., Fomin K.A., Nefyodov L.I., Nowicky J.W., Brzosko W.J., Jankowski A. Influence of Ukrain on Patients with Surgically Treated Breast Cancer. Part I. Clinical and Laboratory Parameters. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 63 - 66.

(71) Uglanica K.N., Fomin K.A., Nefyodov L.I., Vilkiewich T.W., Nowicky J.W., Brzosko W.J., Jankowski A. Influence of Ukrain on Patients with Surgically Treated Breast Cancer. Part II. Hormonal Profile. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 67 - 70.

(72) Uglanica K.N., Fomin K.A., Nefyodov L.I., Djurd T.I., Nowicky J.W., Brzosko W.J., Jankowski A. Influence of Ukrain on Patients with Surgically Treated Breast Cancer. Part III. The Immune System. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 71 -74.

(73) Uglanica K.N., Maciuk J.R., Fomin K.A., Nefyodov L.I., Kravchuk R.I., Vinogradova L. M., Nowicky J.W., Brzosko W.J., Jankowski A. Influence of Ukrain on Patients with Surgically Treated Breast Cancer. Part IV. Electromicroscopic and Cytochemical Evaluation. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 75 - 82.

(74) Nefyodov L.I., Uglanica K.N., Smirnov V.Y., Doroshenko Y.M., Fomin K.A., Nowicky J.W., Brzosko W.J. Amino Acids and Their Derivatives in Blood Plasma of Patients with Breast Cancer Treated with Ukrain. Part V. Drugs Exptl. Clin. Res., XXII (Suppl.), 1996, 83-86.

(75) Nefyodov L.I., Uglanica K.N., Smirnov V.Y., Doroshenko Y.M., Fomin K.A., Nowicky J.W., Brzosko W.J. Amino Acids and Their Derivatives in Tumour Tissue from Patients with Breast Cancer Treated with Ukrain. Part VI. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 87 - 90.

(94) Kadan P., Korsh O.B., Melnyk A. Ukrain Therapy of Recurrent Breast Cancer with Lung Metastases (Case Report). Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 171 - 174.

(95) Nowicky J.W., Schramm E., Godysh Y. Biophysical Effects of Ukrain Therapy in a Patient with Breast Cancer (Case Report). Drugs Exptl Clin Res., Vol XXII (Suppl), 1996, 175-182.

(103) Voltchek I.V., Liepins A., Nowicky J.W., Brzosko W.J. Potential Therapeutic Efficacy of Ukrain (NSC 631570) in Patients with AIDS with Caposi’s Sarcoma. Drugs Exptl. Clin. Res., Vol. XXII (Suppl.), 1996, 211 - 214.

(111) Jagiello-Wojtowicz E., Kleinrok Z., Urbanska E.M. Ukrain (NSC-631570) in experimental and clinical studies: A review. Drugs Exptl. Clin. Res., XXIV (5/6), 213-219.

(114) Uglianitsa K.N., Nefyodov L.I., Brzosko W. Evaluation of the efficacy of Ukrain in the treatment of breast cancer: Clinical and laboratory studies. Drugs Exptl. Clin. Res., XXIV (5/6), 1998, 231-239.

(118) Korolenko T.A, Svechnikova I.G, Filjushina E.E, Kaledin V.I., Vakulin G.M., Usynin I.F., Tsyrendordjiev D.D. Macrophage stimulation and antitumor effect of Ukrain. Drugs Exptl. Clin. Res., XXIV (5/6), 1998, 253-260.

(119) Svechnikova I.G., Korolenko T.A., Stashko J.F., Kaledin V.I., Nikolin V.P., Nowicky J.W. The influence of Ukrain on the growth of HA-1 tumor in mice: The role of cysteine proteinases as markers of tumor malignancy. Drugs Exptl. Clin. Res., XXIV (5/6), 1998, 261-269.

(120) Korolenko T.A., Kaledin V.I., Svechnikova I.G., Li X.V., Stashko J.F., Ilnitskaya S.I., Nikolin V.P. Study of the antitumor effect of ukrain: The role of macrophage secretion of α-1-proteinase inhibitor. Drugs Exptl. Clin. Res., XXIV (5/6), 1998, 271-276.

(123) Kulik GI, Deneka ER, Todor IN, Karmozina LG. Study of acute toxicity of Ukrain in rats after intravenous injection. Drugs Exptl. Clin. Res., XXIV (5/6), 1998, 287-293.

(125) Jagiello-Wojtowicz E., Kleinrok Z., Feldo M., Chodkowska A., Szklarczyk V., Urbanska E.M. Six-week treatment with Ukrain in rabbits. Part II: Serum levels of gonadal hormones. Drugs Exptl. Clin. Res., XXIV (5/6), 1998, 301-304.

(146) Roublevskaia IN, Polevoda BV, Ludlow JW, Haake AR. Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain. Anticancer Res. 2000 Sep-Oct;20(5A):3163-7.

(153) Zemskov V.S., Procopchuk O.L., Susak Y.M., Zemskov S.V., Hodysh Y.Y., Zemskova M.V. Ukrain (NSC 631570) in the treatment of pancreas cancer. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 179-190.

(154) Uglyanitsa K.N., Nechiporenko N.A., Nefyodov L.I., Doroshenko Y.M., Brzosko W., Nowicky W. Results of Ukrain monotherapy of prostate cancer. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 191-193.

(155) Nefyodov L.I., Uglyanitsa K.N., Nechiporenko N.A., Smirnov V.Y., Brzosko W., Karavay N.L. New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 195-199.

(156) Uglyanitsa K.N., Nefyodov L.I., Doroshenko Y.M., Brzosko W.J. Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 201-221.

(157) Uglyanitsa K.N., Nefyodov L.I., Brzosko V. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer Report 1 Clinical aspects of Ukrain application. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 223-230.

(158) Nefyodov L.I., Uglyanitsa K.N., Smirnov V.Y., Karavay A.V., Brzosko W. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 231-237.

(159) Uglyanitsa K.N., Nefyodov L.I., Karayedova L.M., Nowicky J.W., Brzosko W. Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 239-247.

(160) Aschhoff B. Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors. Drugs Exptl. Clin. Res., XXVI(2000), 249-252

(161) Zemskov S.V., Prokopchuk O.L., Susak Y.M. Ukrain treatment in a patient with breast carcinoma. Case report. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 253-254.

(165) Votrin I.I., Voltchek I.V., Kurochkin S.N. Kolobkov S.L. Effects of Ukrain on the activities of DNA-nicking enzymes. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 267-273.

(168) Korolenko T.A., Poteryaeva O.N., Djanayeva S.J., Svechnikova I.G., Kaledin V.I., Timofeyeva O.A., Filipenko M.L., Nowicky J. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 285-292.

(169) Djanayeva S.J., Korolenko T.A., Svechnikova I.G., Falameyeva O.V., Korolenko E., Kaledin V.I., Nowicky J. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 293-299.

(171) Luksa-Lichtenthaler G.L., Ladutko E.I., Nowicky J.W. Influence of Ukrain on the nuclear thyroid hormone receptors after short-term γ-irradiation. Drugs Exptl. Clin. Res., XXVI (5/6), 2000, 307-310.